Open Access<p>ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway</p>
Author(s) -
Ning Sheng,
Wei Qian,
Li Yang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s272621
Subject(s) - hepatocellular carcinoma , cancer research , pi3k/akt/mtor pathway , gene knockdown , cell growth , propidium iodide , protein kinase b , flow cytometry , medicine , apoptosis , biology , immunology , programmed cell death , biochemistry , genetics
Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Although the contradictory role of ADORA1 has been explored in certain types of cancers, its clinical significance and function in hepatocellular carcinoma cells are largely unknown.